Celebrating India’s independence, enterprise and progress
news

Manipal Hospital, Bengaluru Installs India's First Elekta Evo, Advancing AI-Enabled Adaptive Radiotherapy in India

Jul 31, 2026 · Source: cision
Manipal Hospital, Bengaluru Installs India's First Elekta Evo, Advancing AI-Enabled Adaptive Radiotherapy in India

BENGALURU, India, July 31, 2026 -- In a significant advancement for cancer care in India, Manipal Hospital, Yelahanka, Bengaluru has become the first healthcare institution in the country to install Elekta Evo, the company's AI-enhanced adaptive CT-Linac platform. The installation enables clinicians to deliver Online Adaptive Radiotherapy (ART), supporting more personalised and precision-led radiation therapy for patients.

Elekta Evo AI-enhanced adaptive CT-Linac platform

The milestone builds on Evo's India debut at AROICON 2025, the country's premier conference for radiation oncology, held in Kolkata.

According to the Indian Council of Medical Research (ICMR), India continues to witness a growing cancer burden, with an estimated 1.46 million new cancer cases diagnosed annually. As more patients require radiation therapy and many present with complex or advanced-stage disease, the need for technologies that enable greater treatment precision and personalisation has become increasingly important.

For Manipal Hospital, the installation significantly strengthens its radiation oncology capabilities by bringing adaptive radiotherapy into routine clinical practice. This enables clinicians to personalise treatment throughout a patient's care journey, supporting more informed treatment decisions while streamlining clinical workflows. By making adaptive radiotherapy more accessible in routine practice, the platform allows more patients to benefit from personalised radiation therapy without compromising efficiency or precision. The department has already begun translating this capability into clinical practice, successfully treating its first patient with locally advanced rectal cancer using online adaptive radiotherapy (oART) on the Elekta Evo platform. The patient completed neoadjuvant chemoradiotherapy with minimal radiation-related side effects, demonstrating the potential of daily adaptive treatment to precisely target tumors while sparing surrounding healthy tissues.

Feras Al Hasan, Head of Region TIMEA at Elekta, said, "The installation of India's first Elekta Evo at Manipal Hospital marks an important milestone in expanding access to adaptive radiation therapy in the country. Since introducing Evo at AROICON last year, our ambition has been to make this next generation of precision radiation therapy available to clinicians treating increasingly complex cancers. By combining AI-enhanced imaging with online adaptive capabilities on a highly versatile CT-Linac platform, Evo enables clinicians to make more informed treatment decisions throughout a patient's care journey. We are proud to partner with Manipal Hospital in bringing this innovation to India and reaffirm our commitment to advancing high-quality cancer care across the region."

Dr Vikram Maiya, Lead Consultant- Radiation Oncology, Manipal Hospital, Yelahanka, added, "At Manipal Hospital, we are committed to bringing the latest advances in cancer care to our patients. Becoming the first hospital in India to install Elekta Evo reinforces that commitment. The platform enables our radiation oncology teams to adapt treatment to changes in a patient's anatomy during therapy, supporting more individualised treatment decisions while enhancing our ability to deliver personalised, high-quality cancer care. We have already seen its clinical value in patients undergoing online adaptive radiotherapy, where daily treatment adaptation has helped achieve precise tumor targeting while minimising radiation exposure to healthy tissues. Our initial experience across rectal, cervical and prostate cancer patients has been encouraging, with treatments progressing well and minimal side effects observed so far."

Powered by Iris™ high-definition AI-enhanced imaging, Elekta Evo enables clinicians to visualise tumors and surrounding healthy anatomy with exceptional clarity. Combined with online and offline adaptive capabilities, the platform supports a broad range of radiation therapy techniques on a single system, enabling clinicians to deliver highly precise treatment while helping minimise radiation exposure to surrounding healthy tissue.

Adaptive Radiotherapy (ART) is a treatment approach in which a patient's radiation therapy plan is adjusted during the course of treatment to account for changes in anatomy or tumor characteristics. Delivering ART requires high-quality imaging and intelligent software that support accurate visualisation, contouring and rapid treatment planning. Elekta Evo combines Iris™ AI-enhanced imaging with Elekta ONE® Online software to streamline adaptive workflows through distributed treatment planning, AI-assisted contouring and faster dose calculation, enabling clinicians to make informed treatment decisions with greater efficiency and confidence. At Manipal Hospital, Yelahanka, the technology is currently being used to treat patients with cervical, rectal and prostate cancers using online adaptive radiotherapy. While treatment is ongoing, the patients have shown encouraging tolerance to therapy, with minimal treatment-related side effects observed so far.

* Elekta Evo has Central Drugs Standard Control Organization (CDSCO) registration with limited global availability.

**Elekta ONE® is comprised of multiple Elekta solutions, some of which may not yet be available in all markets.

About Elekta

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit https://www.elekta.com

About Manipal Hospitals

Manipal Hospitals is one of India's leading multi-speciality healthcare providers, serving both Indian and international patients. As part of the Manipal Education and Medical Group (MEMG), a renowned leader in the fields of education and healthcare, Manipal Hospitals has established a strong presence across the country. With a network of 49 hospitals spanning 24 cities, it is the second-largest hospital chain in India. The organisation operates through dedicated entities that support the efficient management of its extensive network, ensuring seamless operations, high standards of clinical care, and an enhanced patient experience.

 

Elekta Logo

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/manipal-hospital-bengaluru-installs-indias-first-elekta-evo-advancing-ai-enabled-adaptive-radiotherapy-in-india-302839917.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

TestMu AI Unveils the Fifth Edition of the TestMu Conference in 2026 news
Aug 14, 2026 1 min

TestMu AI Unveils the Fifth Edition of the TestMu Conference in 2026

The world s largest virtual agentic engineering and quality conference returns with a focus on autonomous quality, agentic workflows, and AI-native testing strategies SAN FRANCISCO and NOIDA, India , Aug. 14, 2026 -- TestMu AI (formerly LambdaTest), the world s first Agentic AI-powered Quality Engineering platform, is excited to unveil the 5th edition of its flagship TestMu Conference, taking place virtually from August 19 21, 2026. This year s event is expected to host over 75,000 developers, builders, and quality engineers from more than 120 countries, making it the world s largest virtual conference dedicated to agentic engineering and quality.

Michael Owen Joins ehamarkets as Global Brand Ambassador news
Aug 14, 2026 1 min

Michael Owen Joins ehamarkets as Global Brand Ambassador

HONG KONG and NEW YORK , Aug. 14, 2026 -- ehamarkets today announced a global brand partnership with England football legend and 2001 Ballon d Or winner Michael Owen, who has joined the brand as its Global Brand Ambassador. Owen said he was drawn to ehamarkets focus on technology, reliability and a simpler trading experience. I m delighted to join ehamarkets as its Global Brand Ambassador. I like the way ehamarkets uses technology to make trading simpler and more efficient. It s exciting to be part of a brand that is building a modern trading experience for people around the world.

RemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality news
Aug 14, 2026 1 min

RemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality

The New York-headquartered global Employer of Record renews its SOC 2 Type II attestation for a full 12-month period, adding to its ISO 27001 and GDPR certifications and its recent A+ platform security rating from Astra Security. NEW YORK , Aug. 14, 2026 -- RemotePeople, a global provider of Employer of Record (EOR), payroll, and recruitment services operating in more than 150 countries, today announced the successful completion of its 2026 SOC 2 Type II audit , covering the Security, Availability, and Confidentiality Trust Service Criteria. The independent examination was performed by INTERCERT CPA LLC in accordance with AICPA SSAE 21 attestation standards and covered a continuous 12-month observation period from May 31, 2025 to May 30, 2026.

Bybit TradFi Perpetuals Extend 24/7 Exposure to Over 200 Global Equities and Pre-IPO Assets news
Aug 14, 2026 1 min

Bybit TradFi Perpetuals Extend 24/7 Exposure to Over 200 Global Equities and Pre-IPO Assets

DUBAI, UAE , Aug. 14, 2026 -- Bybit , the world s second-largest cryptocurrency exchange by trading volume, is pleased to announce TradFi Perpetual Contracts now offer over 200 curated TradFi-themed listings , marking one of the highest quality coverage of TradFi derivatives exposure available on a crypto-native platform. The lineup now spans equities, ETFs, precious metals, indices, and oil, with coverage extending across premium US, Hong Kong, South Korean and other equities markets.

Deeper Insights, Better Analytics: Bybit Options Close the Data Gap Between Retail and Institutional Traders news
Aug 14, 2026 1 min

Deeper Insights, Better Analytics: Bybit Options Close the Data Gap Between Retail and Institutional Traders

DUBAI, UAE , Aug. 14, 2026 -- Bybit , the world s second-largest cryptocurrency exchange by trading volume, announced a major upgrade to its Options Data section, introducing a suite of institutional-grade analytics to provide traders with a clearer view of volatility, positioning, and market structure. The redesigned page integrates institutional-grade analytics with a cleaner, more accessible interface for all users. Options trading has been gaining popularity among digital asset derivatives traders, as they increasingly move beyond simple long or short positions to alternative strategies that account for volatility, time decay, and risk management. Options give traders the right, but not the obligation, to buy or sell an asset at a set price before a set date.

Hippocratic AI Unveils Agentic Orchestrators: NYSE Content Update news
Aug 14, 2026 1 min

Hippocratic AI Unveils Agentic Orchestrators: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK , Aug. 14, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today s NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on August 14th Hippocratic AI says it s announced the next generation of healthcare AI Agentic orchestrators feature teams of conversational voice AI agents focused on delivering outcomes. Co-founder and CEO Munjal Shah will join NYSE Live to take viewers through how the new product works. Renewable energy construction company SunScout to celebrate its dual listing SunScout (NYSE American: SNSC) began trading on NYSE American and NYSE Texas earlier this week. CEO Edwin Cywinski and COO Mark Cywinski will join NYSE Live to discuss the milestone. The S&P 500 will look to build off Thursday s record close. The large-cap index surpassed 7,800 for the first time during Thursday s session. Investors are parsing through July U.S. retail sales data.

Binance Research: Gen Z Leads Net Accumulation Across Every TradFi Product news
Aug 14, 2026 1 min

Binance Research: Gen Z Leads Net Accumulation Across Every TradFi Product

New commentary finds 77% of Gen Z direct-equity accounts are net buyers, with 76% accumulating in bStocks, the highest share of any generation. MUMBAI, India , Aug. 14, 2026 -- Binance Research , the market research arm of the world s largest cryptocurrency exchange Binance , has recently published a new weekly market commentary titled Gen Z Perspective Rewrite . The report examines how Gen Z users behave across three TradFi products, namely, direct equities, bStocks, and TradFi-Perps, and finds behavior that is more disciplined and allocation-oriented than common assumptions suggest.

Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock news
Aug 14, 2026 1 min

Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock

NORWALK, Conn. , Aug. 14, 2026 -- (NYSE: BMNR; BMNP) Bitmine Immersion Technologies, Inc. ( Bitmine or the Company ) announced today that its Board of Directors has declared seventeen cash dividends on the Company s 9.50% Series A Perpetual Preferred Stock (the Series A Preferred Stock ), which is listed on the New York Stock Exchange under the trading symbol BMNP . The dividends will be payable in cash in accordance with the terms of the Certificate of Designations governing the Series A Preferred Stock. The record dates, payment dates, and per-share amounts for each dividend are set forth below: